Aethlon Medical Inc (AEMD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AEMD Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Aethlon Medical Inc.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent4.93
Cash & Short-term Investments4.00
Deferred Offering Costs DE0.39
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.28
Total Current Assets5.61
Equipment/Property/Plant Net0.29
Intangible Assets0.00
Deposits Assets, Noncurrent AS0.00
Other Assets, Noncurrent0.33
Operating Lease Right Of Use Asset0.31
Total Assets6.24
Liabilities
Accounts Payable, Current AC0.41
Accrued Professional Fees, Current0.25
Other Liabilities, Current0.37
Total Current Liabilities1.04
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current0.34
Total Liabilities1.04
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock181.89
Retained Earnings / Accumulated Deficit-176.65
Accumulated Other Comprehensive Income-0.04
Other Equity-0.04
Common Stockholder's Equity5.20
Total Stockholder's Equity5.20
Liabilities & Stockholder's Equity6.24
4 historic quarters locked

Sign in to unlock the full Aethlon Medical Inc balance sheet history.

About Aethlon Medical Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-006347

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.